Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kidd

Showing results (151-160 of 157) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 157 results.
Neoplasia (New York, N.Y.)|June 9, 2021
High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneitySusanne G Kidd, Kristina T Carm, Mari Bogaard, et al.
American Journal of Clinical Pathology|December 1, 1990
Secondary T-cell lymphoproliferation after marrow transplantationM M Zutter, D M Durnam, R C Hackman, et al.
Molecular Oncology|May 16, 2022
In situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosisSusanne G Kidd, Mari Bogaard, Kristina T Carm, et al.
Neoplasia (New York, N.Y.)|June 25, 2026
Fusion gene heterogeneity and kinase enrichment in high-grade serous carcinomasIoannis Panagopoulos, Ane Stranger, Anita Sveen, et al.
Cancer Gene Therapy|February 23, 2022
Expressed prognostic biomarkers for primary prostate cancer independent of multifocality and transcriptome heterogeneityJonas M Strømme, Bjarne Johannessen, Susanne G Kidd, et al.
Traffic Injury Prevention|January 21, 2025
RAVE checklist: Recommendations for overcoming challenges in retrospective safety studies of automated driving systemsJohn M Scanlon, Eric R Teoh, David G Kidd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2016
Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription FactorChristy L Osgood, Nichole Maloney, Christopher G Kidd, et al.
Pageof 16

Showing results (151-160 of 157) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
Neoplasia (New York, N.Y.)|June 9, 2021
High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneitySusanne G Kidd, Kristina T Carm, Mari Bogaard, et al.
American Journal of Clinical Pathology|December 1, 1990
Secondary T-cell lymphoproliferation after marrow transplantationM M Zutter, D M Durnam, R C Hackman, et al.
Molecular Oncology|May 16, 2022
In situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosisSusanne G Kidd, Mari Bogaard, Kristina T Carm, et al.
Neoplasia (New York, N.Y.)|June 25, 2026
Fusion gene heterogeneity and kinase enrichment in high-grade serous carcinomasIoannis Panagopoulos, Ane Stranger, Anita Sveen, et al.
Cancer Gene Therapy|February 23, 2022
Expressed prognostic biomarkers for primary prostate cancer independent of multifocality and transcriptome heterogeneityJonas M Strømme, Bjarne Johannessen, Susanne G Kidd, et al.
Traffic Injury Prevention|January 21, 2025
RAVE checklist: Recommendations for overcoming challenges in retrospective safety studies of automated driving systemsJohn M Scanlon, Eric R Teoh, David G Kidd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2016
Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription FactorChristy L Osgood, Nichole Maloney, Christopher G Kidd, et al.
Pageof 16